Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationKidney TransplantationHematopoietic Stem Cell MobilizationTransplantation, HomologousTransplantation ConditioningMelphalanGranulocyte Colony-Stimulating FactorLeukapheresisCombined Modality TherapyHematologic NeoplasmsAntigens, CD34Blood Component RemovalStem Cell TransplantationBone Marrow TransplantationCyclophosphamideMultiple MyelomaTreatment OutcomeGraft SurvivalAntineoplastic Combined Chemotherapy ProtocolsGraft vs Host DiseaseMyeloablative AgonistsBusulfanLiver TransplantationLymphoma, Non-HodgkinHematopoietic Stem CellsEtoposideThiotepaAntineoplastic Agents, AlkylatingRemission InductionImmunosuppressive AgentsRecurrenceRetrospective StudiesCytophagocytosisCarmustineTissue DonorsIfosfamideSalvage TherapyAmyloidosisVincristineTime FactorsCord Blood Stem Cell TransplantationTransplantation ChimeraStem CellsHematopoiesisCytarabineGraft RejectionHodgkin DiseaseDisease-Free SurvivalSurvival RateNeoplasmsSurvival AnalysisWhole-Body IrradiationHistocompatibility TestingInfectionHeart TransplantationHistocompatibilityProspective StudiesLymphoma, T-CellDoxorubicinPrednisonePlatelet CountPOEMS SyndromeTransplantation, IsogeneicFollow-Up StudiesCarboplatinLeukemia, Myeloid, AcuteVidarabineDexamethasoneCytomegalovirus InfectionsLeukemiaBlood Cell CountRecombinant ProteinsCyclosporineBone Marrow PurgingFatal OutcomeAntineoplastic AgentsImmunosuppressionLymphomaGraft vs Leukemia EffectBlood CellsFeasibility StudiesTransplantation ImmunologyAnemia, AplasticMyelodysplastic SyndromesImmunophenotypingHLA AntigensLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLymphocyte DepletionBlood Transfusion, AutologousPrognosisT-LymphocytesCell TransplantationOpportunistic InfectionsHematologic DiseasesMesenchymal Stem Cell TransplantationLeukocytes, MononuclearPrecursor Cell Lymphoblastic Leukemia-LymphomaHistiocytosis, Non-Langerhans-Cell